Target
Proto-oncogene tyrosine-protein kinase Src
Ligand
BDBM81623
Substrate
n/a
Meas. Tech.
Kinase Inhibition Assay
pH
7.4±0
Temperature
277.15±0 K
IC50
67±n/a nM
Citation
 Dalgarno, DStehle, TNarula, SSchelling, Pvan Schravendijk, MRAdams, SAndrade, LKeats, JRam, MJin, LGrossman, TMacNeil, IMetcalf, CShakespeare, WWang, YKeenan, TSundaramoorthi, RBohacek, RWeigele, MSawyer, T Structural basis of Src tyrosine kinase inhibition with a new class of potent and selective trisubstituted purine-based compounds. Chem Biol Drug Des 67:46-57 (2006) [PubMed]  Article 
Target
Name:
Proto-oncogene tyrosine-protein kinase Src
Synonyms:
Calmodulin/Proto-oncogene tyrosine-protein kinase Src | Protein cereblon/Tyrosine-protein kinase SRC | Proto-oncogene c-Src | Proto-oncogene tyrosine-protein kinase Src (c-Src) | SRC | SRC1 | SRC_HUMAN | Tyrosine-protein kinase Src (SRC) | V-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian) | c-Src | p60-Src | pp60c-src
Type:
Protein
Mol. Mass.:
59838.60
Organism:
Homo sapiens (Human)
Description:
P12931
Residue:
536
Sequence:
MGSNKSKPKDASQRRRSLEPAENVHGAGGGAFPASQTPSKPASADGHRGPSAAFAPAAAEPKLFGGFNSSDTVTSPQRAGPLAGGVTTFVALYDYESRTETDLSFKKGERLQIVNNTEGDWWLAHSLSTGQTGYIPSNYVAPSDSIQAEEWYFGKITRRESERLLLNAENPRGTFLVRESETTKGAYCLSVSDFDNAKGLNVKHYKIRKLDSGGFYITSRTQFNSLQQLVAYYSKHADGLCHRLTTVCPTSKPQTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQPGENL
  
Inhibitor
Name:
BDBM81623
Synonyms:
2,6,9-Trisubstitute purine, 9 (AP23451)
Type:
Small organic molecule
Emp. Form.:
C20H29N7O5P2
Mol. Mass.:
509.4357
SMILES:
CCn1cnc2c(Nc3ccc(cc3)P(O)(=O)CP(O)(O)=O)nc(NC3CCC(N)CC3)nc12 |(2.18,-.85,;.69,-.46,;.21,1.01,;1.12,2.25,;.21,3.5,;-1.25,3.02,;-2.58,3.8,;-2.58,5.34,;-1.25,6.11,;-1.25,7.65,;.08,8.42,;1.42,7.65,;1.42,6.11,;.08,5.33,;2.75,8.42,;2.87,6.66,;2.75,9.96,;4.08,9.19,;5.42,8.42,;6.75,9.19,;6.75,7.65,;5.42,6.88,;-3.92,3.02,;-3.92,1.48,;-5.25,.71,;-6.59,1.48,;-6.59,3.03,;-7.92,3.8,;-9.25,3.03,;-10.59,3.79,;-9.25,1.48,;-7.92,.71,;-2.58,.71,;-1.25,1.48,)|
Structure:
Search PDB for entries with ligand similarity: